(Q34583816)

3 August 2017

1 reference

title

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents (English)

1 reference

3 August 2017

1

Chantal Mathieu

1 reference

3 August 2017

Luciano Adorini

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Trends in Molecular Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

174-179

1 reference

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Vitamin D: its role and uses in immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Gene regulation by vitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Vitamin D analogs: mechanism of action and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Recent developments in the use of vitamin D analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATION

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Vitamin D3: a transcriptional modulator of the interferon-gamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Prolongation of allograft survival by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: treatment with 1,25(OH)2D3 restores defect.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Partial protection of 1 alpha-hydroxyvitamin D3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Immunomodulatory role of 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902294-3

7 January 2021

10.1016/S1471-4914(02)02294-3

Identifiers

DOI

1 reference

3 August 2017

1 reference